5.83
Nuvectis Pharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
20.4
FY23:
19.2
FY24:
18.6
FY25:
31.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.82
FY22:
0
FY23:
0
FY24:
0
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
6.66
FY22:
20.4
FY23:
19.2
FY24:
18.6
FY25:
31.7
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.42
FY22:
6.19
FY23:
6.98
FY24:
8.89
FY25:
13.3
(negative)
millions USD
FY21:
0
FY22:
0
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−11.0
FY22:
14.2
FY23:
12.2
FY24:
9.71
FY25:
18.4
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
20.4
FY23:
19.2
FY24:
18.6
FY25:
31.7
All amounts in millions USD